Gilead Sciences
GILD
#102
Rank
NZ$325.16 B
Marketcap
NZ$262.24
Share price
-0.52%
Change (1 day)
35.24%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): NZ$12.69

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$12.96. In 2025 the company made an earnings per share (EPS) of NZ$11.97 an increase over its 2024 EPS that were of NZ$0.66.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$12.696.06%
2025NZ$11.971702.63%
2024NZ$0.66-91.65%
2023NZ$7.9523.98%
2022NZ$6.41-25.86%
2021NZ$8.654850%
2020NZ$0.17-97.64%
2019NZ$7.410.9%
2018NZ$7.3418.71%
2017NZ$6.18-64.88%
2016NZ$17.61-18.45%
2015NZ$21.5955.28%
2014NZ$13.91296.02%
2013NZ$3.5117.89%
2012NZ$2.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.26 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.29-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.59-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$49.31 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.30 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$16.33 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.66-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$29.72 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.25-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA